PRIME THERAPEUTICS for PRIME THERAPEUTICS
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 6, 2009 | $50,000 | Replaced |
| 4th Quarter - Report (this page) | Jan 7, 2009 | $50,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY STEFFL | — |
Insurance INS
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY STEFFL | — |
Pharmacy PHA
pharmaceuticals (HR 5629, HR 1038, S 1695), healthcare reform, health information technology and health information privacy (S. 1693, HR 6357, HR 6898, HR 5442, S 1814), antitrust (HR 971), comparative effectiveness research, Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| JERRY STEFFL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.